Wall Street Breakfast cover image

Merck talks send Cidara soaring

Wall Street Breakfast

00:00

Merck Nears Bid for Sedera Therapeutics

Julie Morgan reports that Merck is close to acquiring Sedera, valuing it above its $3.3B market cap with cash and milestone payments.

Play episode from 00:13
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app